Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Life Science Market Size And Revenue Outlook Through 2030
The life science market has witnessed rapid expansion in recent years. Its value is anticipated to rise from $109.53 billion in 2025 to $123.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Over the past, this growth can be ascribed to elements such as increased pharmaceutical R&D investments, the proliferation of biotechnology companies, the embrace of laboratory automation, a growing need for diagnostics, and the escalating occurrence of chronic and rare diseases.
The life science market size is anticipated to experience substantial growth over the next few years, projected to attain a value of $200.59 billion by 2030, at a compound annual growth rate (CAGR) of 12.9%. This expansion during the forecast period is attributable to breakthroughs in precision medicine, the proliferation of digital health solutions, the integration of AI and big data analytics into research, a rise in collaborations between academic and commercial research institutions, and the broadening of global clinical trials. Prominent trends for this period involve sophisticated drug discovery platforms, unified clinical trial management, high-throughput laboratory automation, regulatory compliance and consulting provisions, and bioinformatics and data analytics.
Get A Free Sample Report With In-Depth Market Insights:
Life Science Market Growth Momentum: What Factors Are Shaping Demand?
The expanding occurrence of chronic illnesses is anticipated to propel the growth of the life science market in the future. These conditions are defined as long-lasting health issues that typically progress slowly and necessitate continuous oversight rather than brief interventions. The rise in chronic diseases is linked to detrimental lifestyle choices such as inadequate nutrition, lack of physical activity, and growing rates of obesity. The field of life science contributes to tackling chronic diseases through facilitating the development of innovative treatments, diagnostic tools, and biologics, thereby enhancing enduring disease management and results for patients. As an illustration, data from the US-based government agency Centers for Disease Control and Prevention revealed in April 2025 that in 2023, 76.4% (equating to 194 million) of adults in the US reported having at least one chronic condition. This included 59.5% of young adults, 78.4% of midlife adults, and 93.0% of older adults, respectively. Consequently, the rising occurrence of chronic illnesses is a key factor boosting the growth of the life science market.
Life Science Market Segments: Where Is Growth Concentrated?
The life science market covered in this report is segmented –
1) By Type: Biotechnology, Pharmaceuticals, Medical Devices, Life Science Tools, Digital Health Solutions
2) By Therapeutic Areas: Oncology, Cardiology, Neurology, Immunology, Rare Diseases, Other Therapeutic Areas
3) By Applications: Drug Discovery And Development, Diagnostics, Therapeutics, Clinical Trials, Research And Development
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions, Hospitals And Clinics
Subsegments:
1) By Biotechnology: Genetic Engineering, Cell Based Technologies, Microbial Biotechnology, Industrial Biotechnology, Agricultural Biotechnology
2) By Pharmaceuticals: Prescription Drugs, Over The Counter Drugs, Generic Drugs, Branded Drugs, Specialty Drugs
3) By Medical Devices: Diagnostic Devices, Therapeutic Devices, Surgical Instruments, Monitoring Devices, Implantable Devices
4) By Life Science Tools: Laboratory Instruments, Reagents And Consumables, Analytical Tools, Sample Preparation Tools, Research Software Solutions
5) By Digital Health Solutions: Health Information Systems, Remote Patient Monitoring, Mobile Health Applications, Clinical Decision Support Systems, Healthcare Data Analytics
Life Science Market Trends Redefining Industry Growth
Leading companies in the life science market are focusing on developing innovative products, such as patented peptide-based functional ingredients, to offer scientifically proven assistance for glucose management and metabolic well-being. These peptide-based functional ingredients are bioactive, short-chain amino acid compounds engineered to engage with particular metabolic pathways to achieve specific health advantages. For instance, in December 2025, Greenyn Biotechnology Co. Ltd., a Taiwan-based provider of proprietary biotechnology-driven functional ingredients and health supplement solutions, launched Insumate mcIRBP-19 Bitter Melon Peptide, a bioactive peptide designed to support metabolic health in dietary supplement applications. The product incorporates a uniquely identified bitter melon-derived peptide that mimics insulin receptor binding activity, aiding in blood glucose control. Its production involves a low-temperature supercritical extraction process, ensuring the preservation of peptide bioactivity and consistency. Insumate mcIRBP-19 is backed by clinical validation and international certifications, establishing it as a next-generation, evidence-based nutraceutical ingredient for the rapidly growing metabolic health and diabetes-support segment.
Life Science Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the life science market are Johnson & Johnson, Roche Holding AG, Pfizer Inc., AbbVie Inc., AstraZeneca plc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., Abbott Laboratories, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Eli Lily and Company, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KGaA, Boehringer Ingelheim International GmbH, Vertex Pharmaceuticals Incorporated, Astellas Pharma Inc., Biogen Inc., bioMérieux SA, Sartorius AG
View The Full Life Science Market Report:
Life Science Market Geographic Distribution And Regional Opportunities
North America was the largest region in the life science market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model